Alcohol and Drug Misuse

A Cochrane Handbook

AvIosief Abraha,Cristina Cusi

Häftad, Engelska, 2012

Del 4 i serien CBS- Cochrane Book Series

592 kr

Beställningsvara. Skickas inom 5-8 vardagar. Fri frakt över 249 kr.

Beskrivning

There is constant pressure for clinicians to practise evidence-based medicine. Cochrane Reviews are an important source of the evidence which informs clinical decisions but can still require considerable time to read and digest. This Cochrane Handbook of Alcohol and Drug Misuse serves as a concise guide to the evidence base for relevant interventions, highlighting the key points of Cochrane reviews for the busy practitioner. Each review is analysed in a structured format, starting with the question, a brief background and a summary answer, followed by the results presented in comprehensive and concise way. The authors then illustrate the value that the review adds to the current knowledge, the main methodological limitations of the included studies and finally the implications of the review’s conclusions for future research.Addiction to drugs and alcohol is an increasing problem that all clinicians have to deal with. This is especially true for medical and family specialists but more so for those dealing with psychiatric, psychological and social problems. The benefit of having the evidence underpinning the clinical approach to all aspects of this topic cannot be underestimated. The book’s comprehensive coverage of interventions provides an authoritative reference for all physicians working with these patients, from family practitioners to clinical specialists and psychiatric specialists. With addiction to drugs and alcohol an increasingly serious morbidity and public health issue, this book from the Cochrane Collaboration will find a wide audience.This title is also available as a mobile App from MedHand Mobile Libraries. Buy it now from iTunes, Google Play or the MedHand Store.

Produktinformation

Utgivningsdatum:2012-09-14
Mått:137 x 211 x 8 mm
Vikt:136 g
Format:Häftad
Språk:Engelska
Serie:CBS- Cochrane Book Series
Antal sidor:168
Förlag:John Wiley and Sons Ltd
ISBN:9780470659694

Utforska kategorier

Missbruk inom Medicin

Mer om författaren

Iosief Abraha MD and Cristina Cusi MD are reviewers in the Cochrane Neurological Network based in Italy. They have carried out Cochrane reviews in a wide range of areas within the Cochrane review groups and specialised in reviewing drug and alcohol withdrawal treatments

Recensioner i media

"Overall the book is a well written, engaging, comprehensive guide to Psychiatry. It is a good beginner’s guide to the practice of psychiatric medicine because it packs relevant information into a tightly condensed bundle." (Asian Journal of Psychiatry, 2013)

Innehållsförteckning

Foreword, ixPreface, xiAcknowledgements, xiiPart 1: AlcoholPsychosocial interventionsChapter 1: Effectiveness of brief alcohol interventions in primary care populations, 1Chapter 2: Brief interventions for heavy alcohol users admitted to general hospital wards, 5Chapter 3: Alcoholics Anonymous and other 12-step programmes for alcohol dependence, 8Chapter 4: Mentoring adolescents to prevent substance use disorders, 10Chapter 5: Universal school-based prevention programmes for alcohol misuse in young people, 12Chapter 6: Universal multicomponent prevention programmes for alcohol misuse in young people, 15Chapter 7: Universal family-based prevention programmes for alcohol misuse in young people, 17Chapter 8: Social norms interventions to reduce alcohol misuse in university or college students, 19Chapter 9: Psychosocial interventions for women enrolled in alcohol treatment during pregnancy, 22Pharmacological interventionsChapter 10: Benzodiazepines for alcohol withdrawal, 24Chapter 11: Anticonvulsants for alcohol withdrawal, 27Chapter 12: Acamprosate for alcohol dependence, 31Chapter 13: Baclofen for alcohol withdrawal, 34Chapter 14: Gamma-hydroxybutyrate for treatment of alcohol withdrawal and prevention of relapse, 36Chapter 15: Psychotropic analgesic nitrous oxide for alcohol withdrawal, 40Chapter 16: Efficacy and safety of pharmacological interventions for the treatment of alcohol withdrawal, 43Chapter 17: Opioid antagonists for alcohol dependence, 46Chapter 18: Pharmacologic interventions for pregnant women enrolled in alcohol treatment, 49Part 2: DrugsPsychosocial interventionsChapter 19: School-based prevention for illicit substance use disorders, 51Chapter 20: Interventions for prevention of substance use disorders by young people delivered in non-school settings, 54Chapter 21: Case management for persons with substance use disorders, 56Chapter 22: Motivational interviewing for substance use disorders, 59Chapter 23: Therapeutic communities for substance use disorders, 62Chapter 24: Interventions for drug-using offenders in the courts, secure establishments and the community, 64Chapter 25: Psychosocial interventions for pregnant women in outpatient illicit drug treatment programmes compared to other interventions, 67Cocaine dependenceChapter 26 Psychosocial interventions for cocaine and psychostimulant amphetamine related disorders, 69Chapter 27: Antidepressants for cocaine dependence, 71Chapter 28: Antipsychotic medications for cocaine dependence, 74Chapter 29: Anticonvulsants for cocaine dependence, 76Chapter 30: Dopamine agonists for cocaine dependence, 78Chapter 31: Disulfiram for the treatment of cocaine dependence, 82Chapter 32: Efficacy of psychostimulant drugs for cocaine dependence, 84Chapter 33: Auricular acupuncture for cocaine dependence, 87Chapter 34: Psychosocial treatment for opiate dependence, 89Chapter 35: Psychosocial and pharmacological treatments versus pharmacological treatments for opioid detoxification, 91Chapter 36: Psychosocial combined with agonist maintenance treatments versus agonist maintenance treatments alone for treatment of opioid dependence, 94Chapter 37: Alpha withdrawal, 96Chapter 38: Buprenorphine for the management of opioid withdrawal, 99Chapter 39: Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence, 102Chapter 40: Methadone at tapered doses for the management of opioid withdrawal, 105Chapter 41: Methadone maintenance at different dosages for opioid dependence, 108Chapter 42: Methadone maintenance therapy versus no opioid replacement therapy for opioid dependence, 110Chapter 43: Opioid antagonists under heavy sedation or anaesthesia for opioid withdrawal, 113Chapter 44: Opioid antagonists with minimal sedation for opioid withdrawal, 115Chapter 45: Oral naltrexone maintenance treatment for opioid dependence, 118Chapter 46: Sustained-release naltrexone for opioid dependence, 121Chapter 47: Heroin maintenance for chronic heroin-dependent individuals, 123Chapter 48: LAAM maintenance versus methadone maintenance for heroin dependence, 126Chapter 49: Detoxification treatments for opiate-dependent adolescents, 129Chapter 50: Maintenance treatments for opiate-dependent adolescents, 131Chapter 51: Maintenance agonist treatments for opiate-dependent pregnant women, 133Chapter 52: Pharmacological treatment for depression during opioid agonist treatment for opioid dependence, 135Chapter 53: Inpatient versus other settings for detoxification for opioid dependence, 138Chapter 54: Psychotherapeutic interventions for cannabis use or dependence in outpatient settings, 140Chapter 55: Pharmacological interventions for benzodiazepine mono-dependence management in outpatient settings, 142Chapter 56: Treatment for amphetamine dependence, 145Chapter 57: Treatment for amphetamine withdrawal, 147Chapter 58: Treatment for amphetamine psychosis, 149Chapter 59: Treatment for methaqualone dependence in adults, 151Index, 153

Mer från samma författare